Cargando…
Regression of metastatic melanoma by targeting cancer stem cells
Current therapeutic regimens attempt to eliminate all malignant cells of a melanoma lesion. Pre-clinical data, however, indicate that melanoma is maintained by a minor subset of cancer cells, which are characterized by CD20 expression. We attempted to eliminate those cells in a progressing, chemothe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292889/ https://www.ncbi.nlm.nih.gov/pubmed/22289880 |